Who owns Array BioPharma?

Key details on Array BioPharma (Ticker: ARRY)

Who owns Array BioPharma?

Is ARRY a good stock to own? Find out who bought Array BioPharma, who sold Array BioPharma (ARRY) stock, and who holds a large position in Array BioPharma.

Fund Name Number of Shares Share Valuation As Of
FMR 18.54M $136.65M March 31, 2015
Redmile 13.13M $96.74M March 31, 2015
Deerfield Management Company 11.83M $87.22M March 31, 2015
OrbiMed Advisors 10.33M $76.15M March 31, 2015
BVF 9.41M $69.32M March 31, 2015
T. Rowe Price Associates 7.61M $56.07M March 31, 2015
Baker Bros. Advisors 5.66M $41.71M March 31, 2015
BlackRock Fund Advisors 5.64M $41.53M March 31, 2015
STATE STREET CORPORATION 4.87M $35.90M March 31, 2015
Vanguard 4.83M $35.61M March 31, 2015
BlackRock Institutional Trust Company, N.A. 4.05M $29.86M March 31, 2015
Gail Mannix 3.93M $18.57M Dec. 31, 2014
TimesSquare Capital Management 3.81M $28.06M March 31, 2015
Artal Group S.A. 3.71M $27.34M March 31, 2015
Kopp Investment Advisors 3.59M $16.29M June 30, 2013
QVT Financial 3.44M $15.61M June 30, 2013
Apex Capital 3.10M $11.07M Sept. 30, 2014

Who sold Array BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management June 30, 2011 4.40M $9.85M